Chronic obstructive pulmonary disease and mortality following hip fracture: a population-based cohort study (original) (raw)

• Cooper C, Campion G, Melton III LJ. Hip fractures in the elderly: A world-wide projection. Osteoporos Int 1992;2:285–89.
  Article PubMed CAS Google Scholar
• Samelson E, Zhang Y, Kiel DP, Hannan MT, Felson DT. Effect of birth cohort on risk of hip fracture: Age- specific incidence rates in the Framingham Study. Am J Pub Health 2002;92:858–62.
  PubMed Google Scholar
• Gullberg B, Johnell O, Kanis JA. Worldwide projections for hip fracture. Osteoporos Int 1997;7(5):407–13.
  Article PubMed CAS Google Scholar
• Nettleman M, Aisip J, Schrader M, Schulte M. Predictors of mortality after acute hip fracture. J Gen Intern Med 1996;11:765–67.
  Article PubMed CAS Google Scholar
• Magaziner J, Simonsick EM, Kashner TM, Hebel JR, Kenzora JE. Excess mortality attributable to white women age 70 or older. Am J Pub Health 1997;87:1630–36.
  Article PubMed CAS Google Scholar
• Poor G, Atkinson EJ, O’Fallon WM, Melton LJ. Determinants of reduced survival following hip fracture in men. Clin Orthop 1995;319:260–65.
  PubMed Google Scholar
• Barrett J, Baron JA, Beach ML. Mortality and pulmonary embolism after fracture in the elderly. Osteoporos Int 2003;14:889–94.
  Article PubMed Google Scholar
• Empana J, Dargent-Molina P, Breart G for the EPIDOS Group. Effect of hip fracture on mortality in elderly women: The EPIDOS Prospective Study. J Am Geriatr Soc 2004;52:685–90.
  Article PubMed Google Scholar
• Roche J, Wenn RT, Sahota O, Moran CG. Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ 2005;331:1374–76.
  Article PubMed CAS Google Scholar
• Johnell O, Kanis JA, Odén A, Sernbo I, Redlund-Johnell I, Petterson C et al. Mortality after osteoporotic fractures. Osteoporos Int 2004;15:38–42.
  Article PubMed CAS Google Scholar
• Meyer H, Tverdal A, Falch JA, Pedersen JI. Factors associated with mortality after hip fracture. Osteoporos Int 2000;11:228–32.
  Article PubMed CAS Google Scholar
• Farahmand B, Michaëlsson K, Ahlbom A, Ljunghall S, Baron JA. Survival after hip fracture. Osteoporos Int 2005;16:1583–90.
  Article PubMed Google Scholar
• Mannino D. Epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. CHEST 2002;121:121S–126S.
  Article PubMed Google Scholar
• Van Staa T, Leufkens HGM, Cooper C. Use of inhaled corticosteroids and risk of fractures. J Bone Mineral Res 2001;16:581–88.
  Article Google Scholar
• Rejnmark L, Olsen ML, Johnsen JP, Vestergaard P, Sørensen HT, Mosekilde L. Hip fracture in statin users: a population-based Danish case–control study. Osteoporos Int 2004;15:452–58.
  PubMed Google Scholar
• Vestergaard P, Olsen ML, Johnsen SP, Rejnmark L, Sørensen HT. Corticosteroid use and risk of hip fracture: a population based case–control study in Denmark. J of Intern Med 2003;254:486–93.
  Article CAS Google Scholar
• de Luise C, Lanes SF, Jacobsen J, Pedersen L, Sørensen HT. Cardiovascular and respiratory hospitalizations and mortality among users of tiotropium in Denmark. Eur J Epidemiol 2007;DOI:10.1007/s10654-007-9106.
• Sørensen H. Regional administrative health registries as a resource in clinical epidemiology. Int J Risk Safety Med 1997;10:1–22.
  Google Scholar
• Andersen T, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263–68.
  PubMed CAS Google Scholar
• Pedersen C, Gøtzsche H, Møller JØ, Mortensen PB. The Danish Civil Registration System. Dan Med Bull 2006;53:441–49.
  PubMed Google Scholar
• Charlson M, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83.
  Article PubMed CAS Google Scholar
• de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol 2003;56:221–29.
  Article PubMed Google Scholar
• Deyo R, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613–19.
  Article PubMed CAS Google Scholar
• Gaist D, Hallas J. The Danish prescription registries. Dan Med Bull 1997;44:445–48.
  PubMed CAS Google Scholar
• Capella D. Drug Utilization Studies: Methods and Uses. In: Descriptive tools, analysis. European Series. Dukes M (ed). Copenhagen: WHO Regional Publicationsl 1993;35:55–58.
• SAS Institute Inc, SAS, version 9.1: Cary, NC.
• Connors A, Dawson NV, Thomas C, Harrell FE, Desbiens N, Fulkerson WJ et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med 1996;154:959–67.
  PubMed Google Scholar
• Fuso L, Incalzi RA, Pistelli R, Muzzolon R, Valente S, Pagliari G et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med 1995;98:272–77.
  Article PubMed CAS Google Scholar
• Seneff M, Wagner DP, Wagner RP, Zimmerman JE, Knaus WA. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995;274:1852–57.
  Article PubMed CAS Google Scholar
• Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. CHEST 2003;124:459–67.
  Article PubMed Google Scholar
• Gulliford M, Charlton J, Latinovic R. Risk of diabetes associated with prescribed glucocorticoids in a large population. Diabetes Care 2006;29(12):2728–29.
  Article PubMed CAS Google Scholar
• McEvoy C, Niewoehner DE. Adverse Effects of Corticosteroid Therapy for COPD: A Critical Review. CHEST 1997;111:732–43.
  Article PubMed CAS Google Scholar
• Hansell A, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J 2003;22:809–14.
  Article PubMed CAS Google Scholar
• Mannino D, Brown C, Giovino GA. Obstructive lung disease in the United States from 1979 to 1993: an analysis using multiple cause mortality data. Am J Respir Crit Care Med 1997;156:814–18.
  PubMed CAS Google Scholar
• Holguin F, Folch E, Redd SC, Mannino DM. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. CHEST 2005;128:2005–2011.
  Article PubMed Google Scholar
• Camilli A, Robbins DR, Lebowitz MD. Death certificate reporting of confirmed airway obstructive disease. Am J Epidemiol 1991;133:795–800.
  PubMed CAS Google Scholar
• Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. CHEST 2005;128:2640–46.
  Article PubMed Google Scholar
• Anthonisen N, Connett JE, Enright PL, Manfreda J. Lung Health Study Research Group Hospitalization and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002;166:333–39.
  Article PubMed Google Scholar
• Sin D, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Resp J 2006;28:1245–57.
  Article CAS Google Scholar
• Soriano J, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of comorbiditiees in newly diagnosed COPD and asthma in primary care. CHEST 2005;128:2099–2107.
  Article PubMed Google Scholar
• Strom K. Survival in patients with chronic obstructive pulmonary disease receiving long-term domiciliary oxygen therapy. Am J Respir Crit Care Med 1993;147:585–91.
  CAS Google Scholar
• Strom K. Oral corticosteroid treatment during long-term oxygen therapy in chronic obstructive pulmonary disease: a risk factor for hospitalization and mortality in women. Respir Med 1998;92:50–56.
  Article PubMed CAS Google Scholar
• Schols A, Wesseling G, Kester AD, de Vries G, Mostert R, Slangen J et al. Dose dependent increase mortality risk in COPD patients treated with oral glucocorticosteroids. Eur Respir J 2001;17:337–42.
  Article PubMed CAS Google Scholar
• Department of Clinical Epidemiology, A.U., Kronisk obstruktiv lungesygdom I Nordjyllands, Viborg og Århus Amter 1994–2004. Forekomst og prognose. 2005.
• Baron J, Barrett J, McLerran D, Fisher ES. Internal validation of Medicare claims data. Epidemiology 1994;5(5):541–44.
  PubMed CAS Google Scholar
• Fisher E, Whaley FS, Krushat WM, Malenka DJ, Fleming C, et al. The accuracy of Medicare’s hospital claims data: progress has been made, but problems remain. Am J Public Health 1992;82:243–48.
  PubMed CAS Google Scholar
• Rothman K, Greenland S. Precision and validity of studies. In: Modern Epidemiology. 2nd ed. Rothman K, Greenland S (eds). Philadelphia: Lippencott-Raven, 1998. 126–32.
  Google Scholar
• Sundhedsstyrelsen. Monitoring smoking habits in the Danish population. 2005 [cited Oct 26, 2007];Available from: http://www.sst.dk/upload/forebyggelse/cff/tobak/tabeller_2005/kryds2005_alle.pdf.
• Mannino D, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic Obstructive Pulmonary Disease Surveillance - United States, 1971–2000. MMWR 2002;51(SS06):1–16.
  Google Scholar